Abstract
Objective: To determine prevalence of hepatitis B virus (HBV) serological markers in Chinese residents in the United Kingdom.
Method: Retrospective case-controlled study between January 1997 and June 2000 in two genitourinary medicine (GUM) clinics.
Results: 117 Chinese and 234 non-Chinese controls were studied. Baseline characteristics except marital status showed no difference. Overall prevalence of HBV serological markers was 35.8% in Chinese, controls 5.5% (p<0.001). Hepatitis B surface antigen (HBsAg) positive carrier rate was 12.8% in Chinese, controls 0.4% (p<0.001); 1.7% of Chinese patients were also hepatitis B e antigen (HBeAg) positive, none in controls. Natural immunity was acquired in 23.0% of Chinese, controls 5.1% (p<0.001). Prevalence of HBV serological markers in UK born Chinese was 6.7%, non-UK born Chinese 40.1% (p<0.011). Only 7.6% of Chinese had a history of previous HBV vaccination.
Conclusions: Prevalence of HBV serological markers among Chinese patients attending two GUM clinics in London was high and only a minority of Chinese had immunisation against HBV. Although the prevalence of HBV markers in UK born Chinese was lower than non-UK born Chinese, they may be at continuous risk of HBV infection. Non-UK born Chinese patients attending GUM services in the United Kingdom should be targeted for screening and vaccination to reduce HBV transmission.
Full Text
The Full Text of this article is available as a PDF (82.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boxall E., Skidmore S., Evans C., Nightingale S. The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol Infect. 1994 Dec;113(3):523–528. doi: 10.1017/s0950268800068539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brook M. G., Lever A. M., Kelly D., Rutter D., Trompeter R. S., Griffiths P., Thomas H. C. Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital. Q J Med. 1989 Apr;71(264):313–317. [PubMed] [Google Scholar]
- Chadwick R. G., Hall A. J., Davidson I., Bull F. G., Wright R. Hepatitis B among Indochinese refugees in Great Britain. Postgrad Med J. 1982 Nov;58(685):676–679. doi: 10.1136/pgmj.58.685.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gan C. Y., Yap S. F., Ngeow Y. F., Wong H. C. Hepatitis B infection among Chinese STD patients in Kuala Lumpur, Malaysia. Sex Transm Dis. 1991 Apr-Jun;18(2):84–88. doi: 10.1097/00007435-199118020-00006. [DOI] [PubMed] [Google Scholar]
- Gilson R. J., de Ruiter A., Waite J., Ross E., Loveday C., Howell D. R., Tedder R. S., Weller I. V. Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage. Sex Transm Infect. 1998 Apr;74(2):110–115. doi: 10.1136/sti.74.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Godley M. J., Laidler P. W., Banatvala J. E. Hepatitis B in a West Indian population in the United Kingdom. Br Med J (Clin Res Ed) 1986 Feb 8;292(6517):375–375. doi: 10.1136/bmj.292.6517.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldberg D., McMenamin J. The United Kingdom's hepatitis B immunisation strategy--where now? Commun Dis Public Health. 1998 Jun;1(2):79–83. [PubMed] [Google Scholar]
- Kane M. Global programme for control of hepatitis B infection. Vaccine. 1995;13 (Suppl 1):S47–S49. doi: 10.1016/0264-410x(95)80050-n. [DOI] [PubMed] [Google Scholar]
- Liaw Y. F., Leung N. W., Chang T. T., Guan R., Tai D. I., Ng K. Y., Chien R. N., Dent J., Roman L., Edmundson S. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology. 2000 Jul;119(1):172–180. doi: 10.1053/gast.2000.8559. [DOI] [PubMed] [Google Scholar]
- Lok A. S., Lai C. L., Wu P. C., Leung E. K. Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection. Lancet. 1988 Aug 6;2(8606):298–302. doi: 10.1016/s0140-6736(88)92355-0. [DOI] [PubMed] [Google Scholar]
- Lok A. S., Lai C. L., Wu P. C., Wong V. C., Yeoh E. K., Lin H. J. Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol. 1987 Sep;126(3):492–499. doi: 10.1093/oxfordjournals.aje.a114681. [DOI] [PubMed] [Google Scholar]
- Maynard J. E. Hepatitis B: global importance and need for control. Vaccine. 1990 Mar;8 (Suppl):S18–S23. doi: 10.1016/0264-410x(90)90209-5. [DOI] [PubMed] [Google Scholar]
- Tang K. Y. Hepatitis B, 1997 and the Chinese community--an appraisal of their relationships. J Public Health Med. 1997 Jun;19(2):200–202. doi: 10.1093/oxfordjournals.pubmed.a024609. [DOI] [PubMed] [Google Scholar]
- Van Damme P., Kane M., Meheus A. Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board. BMJ. 1997 Apr 5;314(7086):1033–1036. doi: 10.1136/bmj.314.7086.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watt I. S., Howel D., Lo L. The health care experience and health behaviour of the Chinese: a survey based in Hull. J Public Health Med. 1993 Jun;15(2):129–136. [PubMed] [Google Scholar]
- Yao G. B. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38 (Suppl 2):S39–S42. doi: 10.1136/gut.38.suppl_2.s39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- el-Dalil A. A., Jayaweera D. T., Walzman M., Radcliffe K. W., Richmond R., Wade A. A., Shahmanesh M. Hepatitis B markers in heterosexual patients attending two genitourinary medicine clinics in the West Midlands. Genitourin Med. 1997 Apr;73(2):127–130. doi: 10.1136/sti.73.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]